Bio China International Convention 2026

BIOCHINA, organized by Enmore BIO, is a key event in the biotechnology sector.

Every March, it brings together around 30,000 people from all over the world to share ideas, collaborate, and advance in this field. With a focus on health, BIOCHINA aims to leverage biotechnology to address major global challenges.

Attending BIOCHINA is an opportunity to boost drug licensing, as well as to discover drugs in preclinical, clinical, and marketed stages. The event enables optimization of the supply chain by connecting with more than 500 suppliers of instruments, devices, consumables, and reagents. Additionally, it offers a platform to promote products and reach over 3,000 biotechnology companies in China.

• Early Research and Clinical Development

A space dedicated to scientific and clinical advances in the discovery and validation of new therapies, addressing topics such as AI applied to drug development, CAR-T therapies, mRNA, gene therapy, radiopharmaceuticals, and new clinical trial models.

• Process Development and Quality

  An area focused on optimizing biopharmaceutical manufacturing and global regulatory compliance, including upstream and downstream development, analytical and quality control, international CMC expansion, and the implementation of AI in manufacturing.

• BD Deals and Global Markets

  A section focused on business strategies, investment, and international expansion, featuring forums on licensing deals and partnerships, biotech financing, intellectual property, and market opportunities in Asia, India, the Middle East, and Latin America.

• Procurement and Supply Chain

  A space dedicated to strategic management of procurement and supply chains in the biopharmaceutical sector, covering global supply chains, sourcing for cell and gene therapies (CGT), collaboration with CXOs, and localization of critical materials.